Latest BioMarin Pharmaceutical Stories
WASHINGTON, April 10, 2015 /PRNewswire-USNewswire/ -- On May 19, the National Organization for Rare Disorders (NORD)®, the nation's leading nonprofit organization dedicated to helping patients with
WASHINGTON, Feb. 24, 2015 /PRNewswire-USNewswire/ -- Over 200 patient advocates are in Washington D.C.
RnRMarketResearch.com adds "Fatigue - Pipeline Review, H1 2015" to its store. This provides an overview of the Fatigue's therapeutic pipeline. DALLAS, Feb.
Former ABC Anchor and Lung Cancer Survivor Greta Kreuz to MC WASHINGTON, Nov.
RnRMarketResearch.com adds “Colon Cancer and Ovarian Cancer – Pipeline Review, H2 2014” to its store.
Editor Note: For more information about this release, please scroll to bottom. LONDON, October 20, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on
Editor Note: For more information about this release, please scroll to bottom. LONDON, September 10, 2014 /PRNewswire/ -- On Tuesday, September 09, 2014, the NASDAQ
TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Approval delivers first pharmaceutical therapy for children and adults with ultra-rare, life-limiting disorder TORONTO, July 7, 2014 /CNW/ - BioMarin Pharmaceutical Inc.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.